Royal Bank of Canada’s Bright Minds Biosciences DRUG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Sell |
65
-524
| -89% | -$16.1K | ﹤0.01% | 6402 |
|
|
2025
Q1 | $21K | Sell |
589
-229
| -28% | -$8.17K | ﹤0.01% | 5515 |
|
|
2024
Q4 | $29K | Buy |
818
+158
| +24% | +$5.6K | ﹤0.01% | 5454 |
|
|
2024
Q3 | $1K | Buy |
660
+150
| +29% | +$227 | ﹤0.01% | 6227 |
|
|
2024
Q2 | $1K | Sell |
510
-102
| -17% | -$200 | ﹤0.01% | 6410 |
|
|
2024
Q1 | $1K | Buy |
612
+334
| +120% | +$546 | ﹤0.01% | 6326 |
|
|
2023
Q4 | $0 | Buy |
278
+182
| +190% | – | ﹤0.01% | 6647 |
|
|
2023
Q3 | $0 | Sell |
96
-387
| -80% | – | ﹤0.01% | 6645 |
|
|
2023
Q2 | $1K | Buy |
483
+67
| +16% | +$139 | ﹤0.01% | 6527 |
|
|
2023
Q1 | $1K | Buy |
416
+43
| +12% | +$103 | ﹤0.01% | 6483 |
|
|
2022
Q4 | $1K | Buy |
373
+54
| +17% | +$145 | ﹤0.01% | 6544 |
|
|
2022
Q3 | $2K | Buy |
319
+3
| +0.9% | +$19 | ﹤0.01% | 6511 |
|
|
2022
Q2 | $1K | Buy |
316
+268
| +558% | +$848 | ﹤0.01% | 6638 |
|
|
2022
Q1 | $0 | Buy |
+48
| New | – | ﹤0.01% | 7267 |
|